Auromedics

Date: 01/28/2022

Product Decsription

Polymyxin B for Injection USP, 500,000 Units/Vial

Recall Reason Description

Presence of Particulate Matter

Company Name

AuroMedics Pharma LLC

US FDA Link:   https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/auromedics-pharma-llc-issues-voluntary-nationwide-recall-polymyxin-b-injection-usp-500000-unit-vial

Leave a Reply